Zobrazeno 1 - 10
of 185
pro vyhledávání: '"Jin-Seok Ahn"'
Autor:
Seok Won Kim, Seok Jin Nam, Young-Hyuck Im, Se Kyung Lee, Yeon Hee Park, Jonghan Yu, Ji-Yeon Kim, Byung Joo Chae, Jai Min Ryu, Jin Seok Ahn
Publikováno v:
Cancer Research. 81:PS10-38
Introduction Adding pertuzumab(P) on trastuzumab(H) with cytotoxic chemotherapy increased pathologic complete response (pCR) of early or locally advanced HER2 positive breast cancer (EBC) with neoadjuvant chemotherapy. Since 63.6% of pCR rate has bee
Autor:
Hyun Ae Jung, Se-Hoon Lee, Joon Young Hur, Myung-Ju Ahn, Jong-Mu Sun, Joon Ho Shim, Bo Mi Ku, Keunchil Park, Jin Seok Ahn
Publikováno v:
In Vivo. 34:1399-1406
Background/aim MET exon 14 skipping occurs in 3-4% of patients with lung adenocarcinomas. In this study, we performed a comprehensive analysis of clinical data from Korean non-small cell lung cancer (NSCLC) patients with MET exon 14 skipping. Patient
Autor:
Mi Hwa Heo, Hansang Lee, Yeon Hee Park, Young-Hyuck Im, Ji-Yeon Kim, Jin Seok Ahn, Hee Kyung Kim
Publikováno v:
The Korean Journal of Internal Medicine, Vol 34, Iss 5, Pp 1100-1106 (2019)
The Korean Journal of Internal Medicine
The Korean Journal of Internal Medicine
Background/aims We conducted a retrospective analysis of the clinical activity of fulvestrant in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) previously t
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
In this study, we evaluated clinical parameters to predict the primary resistance of palbociclib in combination with endocrine therapy as the first-line treatment in patients with hormone receptor (HR)+, human epidermal growth factor receptor 2 (HER2
Autor:
Moon Young Choi, Eun Kyung Cho, Hoon Gu Kim, Jinhyun Cho, Hye Ryun Kim, Ha Yeon Lee, Heui June Ahn, Keunchil Park, Ki Hyeong Lee, Myung-Ju Ahn, Hwan Jung Yun, Jin Hyoung Kang, Se-Hoon Lee, Su Jin Lee, K.H. Yoo, Yoonhee Choi, Sin-Ho Jung, Jong Mu Sun, Keon Uk Park, Jin Seok Ahn, Jaeheon Jeong, Kihwan Kim
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose The optimal cytotoxic regimens have not been established for patients with non-small cell lung cancer (NSCLC) who develop disease progression on first-line epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). Materials and m
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose We tried to evaluate whether there are any specific features in treatment outcomes of firstline afatinib in patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), compared with gefitinib or erlotinib.
Autor:
Richard Chye, Jin Seok Ahn, Kristal Cielo Buemio, Mariana Palladini, Brian Le, Hayati Yaakup, Henry Lu, Yu Yun Shao, Gabriel Olarte, Amar Salti, Yacine Hadjiat, Tony O'Brien, Consuelo Gutierrez Colin
Publikováno v:
Journal of Opioid Management. 15:147-158
Transdermal buprenorphine (TDB) has demonstrated effectiveness in treating a range of chronic pain conditions, including cancer pain, nociceptive pain, and neuropathic pain and has a favorable safety profile. Worldwide, clinical experience of its use
Autor:
Hye Sook Han, Jung Yong Kim, Jee Hyun Kim, Seock-Ah Im, Young-Hyuck Im, Jin Seok Ahn, Joohyuk Sohn, Keun Seok Lee, Kyung Hun Lee, Tae Yong Kim, Yeon Hee Park, Ki Hyeong Lee, Jin-Hee Ahn, Se Hyun Kim, In Hae Park, Jahoon Kang, Sung-Bae Kim, Gun Min Kim, Kyung Hae Jung
Publikováno v:
International Journal of Cancer. 143:3240-3247
Although the introduction of human epidermal growth factor receptor (HER)2-directed therapy including trastuzumab, pertuzumab, lapatinib and trastuzumab emtansine (T-DM1) in the treatment of HER2-positive metastatic breast cancers (mBCs) favorably ch
Autor:
Jeong Eon Lee, Young-Hyuck Im, Se Kyung Lee, Yeon Hee Park, Hye Won Hwang, H.N. Jung, Seok Won Kim, Jin Seok Ahn, Misun Choi, Eun Yoon Cho, Seok Jin Nam, Jiyeon Hyeon, Jonghan Yu, Soo Youn Cho
Publikováno v:
Breast Cancer Research and Treatment. 173:255-266
The value of tumor-infiltrating lymphocytes (TILs) for prediction of pathologic complete response (pCR) in breast cancer (BC) patients treated with neoadjuvant chemotherapy (NAC) has received increasing attention. In human epidermal growth factor rec
Autor:
Jong Mu Sun, Se-Hoon Lee, Hansang Lee, Keunchil Park, Hee Kyung Kim, Sung-min Kim, Jang Ho Cho, Sung Won Lim, Myung-Ju Ahn, Jin Seok Ahn, Song Ee Park, Youjin Kim, Sehhoon Park
Publikováno v:
Lung Cancer. 124:293-297
Objectives Several studies have demonstrated the promise of continuation of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) beyond progression in patients with EGFR-mutant non-small-cell lung cancer (NSCLC). The aim of the pre